YD Bio (YDESW) Long-Term Investments (2025)
YD Bio's (YDESW) quarterly Long-Term Investments came in at -$96276.0 in Q2 2025.
Powered by 
Analysis
YD Bio (YDESW) Long-Term Investments (2025) Analysis & Trends
YD Bio (YDESW) has reported Long-Term Investments for 1 consecutive years, with -$96276.0 the latest figure, recorded in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 212.05 Bn | 198.06 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 181.76 Bn | 178.58 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 132.46 Bn | 124.61 Bn | 2.84 Bn | 5.79 Bn |
| 4 | Regeneron Pharmaceuticals | 82.66 Bn | 74.67 Bn | 3.93 Bn | 9.83 Bn |
| 5 | Argenx Se | 61.56 Bn | 56.37 Bn | 1.37 Bn | -4.00 Mn |
| 6 | Moderna | 54.69 Bn | 49.56 Bn | 52.00 Mn | 1.77 Bn |
| 7 | Alnylam Pharmaceuticals | 34.18 Bn | 30.87 Bn | 992.69 Mn | 22.17 Mn |
| 8 | Biogen | 31.46 Bn | 30.17 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 30.15 Bn | 30.15 Bn | 1.16 Mn | - |
| 10 | YD Bio | 29.02 Mn | 26.36 Mn | - | - |